Visionary has limited spots available for accredited investors at a luncheon presentation on March 24th in NYC. Upon RSVP, Visionary and the event hosts will then be in touch regarding event details. To request materials/a private meeting in NYC or by phone, please reply directly.
You are cordially invited to hear from a leading regenerative medicine company developing novel cell therapy products, which require no tissue matching prior to administration. The cells release a range of therapeutic proteins in response to inflammation, ischemia, muscle trauma, hematological disorders, and radiation damage. The company already has 3 drugs in phase 3 clinical studies.